Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last $115.04 USD
Change Today -0.97 / -0.84%
Volume 8.8M
As of 8:10 PM 07/2/15 All times are local (Market data is delayed by at least 15 minutes).

Audit Committee* - gilead sciences inc (GILD)

Name (Connections)Board RelationshipsTitleKey Developments
Nicholas Moore 49 RelationshipsIndependent Director, Chairman of Audit Committee and Member of Compensation Committee 
John Madigan 338 RelationshipsIndependent Director, Chairman of Compensation Committee and Member of Audit Committee 
John Cogan Ph.D. 54 RelationshipsLead Independent Director, Member of Audit Committee and Member of Scientific Committee 
Kevin Lofton FACHE 69 RelationshipsIndependent Director, Member of Audit Committee and Member of Compensation Committee 

Compensation Committee* - gilead sciences inc (GILD)

Name (Connections)Board RelationshipsTitle
Kevin Lofton FACHE 69 RelationshipsIndependent Director, Member of Audit Committee and Member of Compensation Committee
John Madigan 338 RelationshipsIndependent Director, Chairman of Compensation Committee and Member of Audit Committee
Nicholas Moore 49 RelationshipsIndependent Director, Chairman of Audit Committee and Member of Compensation Committee
Per Wold-Olsen MBA 51 RelationshipsIndependent Director, Member of Compensation Committee and Member of Scientific Committee
GILD Compensation vs. Industry
1.6M
363.4K
Chief Executive Officer
797.6K
265.7K
Chief Financial Officer
1.0M
345.1K
Chief Operating Officer
Share price activity for GILEAD SCIENCES INC (GILD)
52 Week Price Performance
GILD
Industry Average

Nominating Committee* - gilead sciences inc (GILD)

Name (Connections)Board RelationshipsTitleKey Developments
Gayle Wilson 41 RelationshipsIndependent Director, Chairman of Nominating & Corporate Governance Committee and Member of Scientific CommitteeGilead Sciences, Inc. Announces Executive Promotions
01/28/15
Richard Whitley M.D., Ph.D. 154 RelationshipsIndependent Director, Member of Independent Health Policy Advisory Board, Chairman of Scientific Committee and Member of Nominating & Corporate Governance CommitteePhilippe C. Bishop to Join Gilead Sciences Inc. as Senior Vice President, Hematology and Oncology Therapeutics
12/15/14
Vicomte Davignon 84 RelationshipsIndependent Director and Member of Nominating & Corporate Governance CommitteeGilead Sciences Inc. Announces Executives Promotions
01/27/14
Carla Hills 231 RelationshipsIndependent Director and Member of Nominating & Corporate Governance CommitteeGilead Sciences, Inc. Announces Retirement of Kevin Young CBE as Executive Vice President, Commercial Operations, Effective February 04, 2014
01/6/14

Corporate Governance Committee* - gilead sciences inc (GILD)

Name (Connections)Board RelationshipsTitle
Vicomte Davignon 84 RelationshipsIndependent Director, Member of Audit Committee and Member of Compensation Committee
Carla Hills 231 RelationshipsIndependent Director, Chairman of Compensation Committee and Member of Audit Committee
Richard Whitley M.D., Ph.D. 154 RelationshipsIndependent Director, Chairman of Audit Committee and Member of Compensation Committee
Gayle Wilson 41 RelationshipsIndependent Director, Member of Compensation Committee and Member of Scientific Committee
GILD and Competitor
Insiders vs. External
Board
7%
93%
Gilead Sciences Inc.
8%
92%
Amgen Inc.
23%
77%
GlaxoSmithKline plc
8%
92%
Merck & Co. Inc.
7%
93%
Sanofi
11%
89%
AbbVie Inc.
Insiders
External Board Members

Executive Committee* - gilead sciences inc (GILD)

Name (Connections)Board RelationshipsTitle
John McHutchison M.D., FRACP 30 RelationshipsExecutive Vice President of Clinical Research
Management Effectiveness Relative to the Industry
Return on Equity
5.9x
Return on Assets
NM
Return on Total Capital
5.6x
TEV/Total Revenue(LTM)
5.6x

Advisory Committee* - gilead sciences inc (GILD)

Name (Board Relationships)/Title Board Affiliations
Kenneth Anderson 124 Relationships
Member of the Scientific Advisory Board
No other board affiliations
Paul Berg 45 Relationships
Member of Scientific Advisory Board
No other board affiliations
Seth Berkley 90 Relationships
Member of Health Policy Advisory Board
No other board affiliations
Paul Boateng 42 Relationships
Member of Health Policy Advisory Board
No other board affiliations
Francis Chisari 54 Relationships
Member of the Scientific Advisory Board
No other board affiliations
Michael Drake 52 Relationships
Member of Health Policy Advisory Board
No other board affiliations
Brian Druker 153 Relationships
Member of the Scientific Advisory Board
No other board affiliations
Richard Feachem 60 Relationships
Chairperson of Health Policy Advisory Board
No other board affiliations
David Gollaher 72 Relationships
Member of Health Policy Advisory Board
No other board affiliations
Robert Harrington 29 Relationships
Member of the Scientific Advisory Board
No other board affiliations
Joel Huff 44 Relationships
Chairperson of Scientific Advisory Board
No other board affiliations
Hannah Kettler 29 Relationships
Member of Health Policy Advisory Board
No other board affiliations
Paul Klotman 29 Relationships
Member of the Scientific Advisory Board
No other board affiliations
John Mellors 46 Relationships
Member of the Scientific Advisory Board
No other board affiliations
Calvin Pan 29 Relationships
Member of Health Policy Advisory Board
No other board affiliations
Eugene Schiff 46 Relationships
Member of the Scientific Advisory Board
No other board affiliations
Robert Schooley 118 Relationships
Member of the Scientific Advisory Board
No other board affiliations
Robert Shapiro 29 Relationships
Member of Health Policy Advisory Board
No other board affiliations
Eric Topol 202 Relationships
Member of Scientific Advisory Board
No other board affiliations
Richard Whitley 154 Relationships
Independent Director, Member of Independent Health Policy Advisory Board, Chairman of Scientific Committee and Member of Nominating & Corporate Governance Committee
No other board affiliations
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
GILD:US $115.04 USD -0.97

GILD Competitors

Market data is delayed at least 15 minutes.

Company Last Change
AbbVie Inc $68.21 USD -0.30
Amgen Inc $153.26 USD -1.73
GlaxoSmithKline PLC 1,348 GBp -7.50
Merck & Co Inc $57.67 USD +0.07
Sanofi €88.18 EUR -0.90
View Industry Companies
 

Industry Analysis

GILD

Industry Average

Valuation GILD Industry Range
Price/Earnings 13.1x
Price/Sales 6.2x
Price/Book 9.9x
Price/Cash Flow 11.9x
TEV/Sales 5.2x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact GILEAD SCIENCES INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.